review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Yong-Jun Wang | |
Liqun Zhang | |||
Chun-Juan Wang | |||
Chun-Xue Wang | |||
Yi-Long Wang | |||
P2860 | cites work | Stenting versus endarterectomy for treatment of carotid-artery stenosis | Q24619941 |
Genome-wide association study of intracranial aneurysm identifies three new risk loci | Q24630663 | ||
Susceptibility loci for intracranial aneurysm in European and Japanese populations | Q24643743 | ||
The use of embolic signal detection in multicenter trials to evaluate antiplatelet efficacy: signal analysis and quality control mechanisms in the CARESS (Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic carotid Stenosis) trial | Q28195492 | ||
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial | Q28209556 | ||
Protected carotid-artery stenting versus endarterectomy in high-risk patients | Q28286624 | ||
Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association | Q28296349 | ||
Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke | Q29619330 | ||
Tissue plasminogen activator for acute ischemic stroke | Q29619377 | ||
Asymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): a prospective observational study | Q30480493 | ||
Short-term outcome after stenting versus endarterectomy for symptomatic carotid stenosis: a preplanned meta-analysis of individual patient data | Q33690251 | ||
Physical activity and risk of stroke in women | Q33875980 | ||
Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial. | Q34136829 | ||
Risk score for in-hospital ischemic stroke mortality derived and validated within the Get With the Guidelines-Stroke Program | Q34140489 | ||
Anti-oxidant properties of high-density lipoprotein and atherosclerosis | Q34440172 | ||
Characteristics, performance measures, and in-hospital outcomes of the first one million stroke and transient ischemic attack admissions in get with the guidelines-stroke | Q34617016 | ||
Multivariate analysis of risk factors of hematoma expansion in spontaneous intracerebral hemorrhage | Q37022256 | ||
High-density lipoprotein: a potent inhibitor of inflammation | Q37636513 | ||
Development of stroke performance measures: definitions, methods, and current measures | Q37757910 | ||
Embolus extravasation is an alternative mechanism for cerebral microvascular recanalization | Q39699887 | ||
Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial | Q39889215 | ||
New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the International Carotid Stenting Study (ICSS). | Q39896651 | ||
Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT). | Q39913472 | ||
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials | Q39933423 | ||
Lower treatment blood pressure is associated with greatest reduction in hematoma growth after acute intracerebral hemorrhage | Q39949496 | ||
Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors | Q40528209 | ||
Robot-assisted therapy for long-term upper-limb impairment after stroke | Q41406624 | ||
Antihypertensive treatment of acute cerebral hemorrhage | Q41502033 | ||
Rapid change in prescribing behavior in hospitals participating in get with the guidelines-stroke after release of the management of atherothrombosis with clopidogrel in high-risk patients (MATCH) clinical trial results | Q42969008 | ||
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study | Q43012682 | ||
Atorvastatin increases expression of low-density lipoprotein receptor mRNA in human circulating mononuclear cells | Q43237527 | ||
Get With the Guidelines-Stroke performance indicators: surveillance of stroke care in the Taiwan Stroke Registry: Get With the Guidelines-Stroke in Taiwan | Q43426637 | ||
Race/ethnicity, quality of care, and outcomes in ischemic stroke | Q45354954 | ||
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials | Q47963971 | ||
Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke | Q48345920 | ||
Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators | Q48367061 | ||
Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. | Q48468454 | ||
Early hemorrhage growth in patients with intracerebral hemorrhage | Q48821770 | ||
Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. | Q51116585 | ||
30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. | Q51122306 | ||
Stent-protected angioplasty in asymptomatic carotid artery stenosis vs. endarterectomy: SPACE2 - a three-arm randomised-controlled clinical trial. | Q51135640 | ||
Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. | Q53624376 | ||
Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) | Q55063586 | ||
Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial | Q57313084 | ||
P433 | issue | 9 | |
P304 | page(s) | 562-569 | |
P577 | publication date | 2011-09-01 | |
P1433 | published in | Clinical and Experimental Pharmacology and Physiology | Q5133807 |
P1476 | title | Advances in stroke care and research in 2010. | |
P478 | volume | 38 |
Q50950537 | Enhanced Neuroprotection of Minimally Invasive Surgery Joint Local Cooling Lavage against ICH-induced Inflammation Injury and Apoptosis in Rats. |
Q48597578 | High-sensitivity C-reactive protein is a strong risk factor for death after acute ischemic stroke among Chinese |
Q41678497 | The American Heart Association's Get With the Guidelines (GWTG)-Stroke development and impact on stroke care |
Search more.